Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
23andMe Holding (ME)
NASDAQ:ME
Holding ME?
Track your performance easily
Earnings Data
Report Date
Feb 05, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2024
|% Change Since: -29.07%
|Next Earnings Date:Feb 05, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative developments. While there were significant achievements in board reconstitution, subscription service growth, and improved financial metrics, the company faced challenges with revenue decline, discontinuation of therapeutic programs, and financial liquidity concerns.Company Guidance
During the Q2 2025 earnings call, 23andMe provided significant guidance on their financial and strategic direction. The company reported a revenue of $44 million, representing a 12% decrease from the previous year, primarily due to declines in consumer services and research services revenue. Despite this, they achieved a 21% improvement in GAAP net loss and a 26% improvement in adjusted EBITDA compared to the prior year. The restructuring efforts, including reducing their workforce by approximately 40% and discontinuing therapeutic programs, are expected to result in annualized cost savings of at least $35 million. The company aims to focus on increasing subscription revenue, which grew to represent 21% of total revenue, and exploring collaborations in their database business. Additionally, they are working towards out-licensing their Therapeutics programs to ensure continued development outside of 23andMe. With cash and cash equivalents standing at $127 million, 23andMe is prioritizing financial stability and sustainable growth, including regaining compliance with Nasdaq listing requirements and considering raising additional capital.Board Reconstitution and Nasdaq Compliance
23andMe reconstituted its Board of Directors with three new Independent Directors and regained compliance with Nasdaq listing standards.
Significant Progress in Subscription Services
The company more than doubled its recurring revenue percentage from 9% in the prior year quarter to over 21% in Q2.
Launch of Total Health Membership Service
Introduced a comprehensive longevity platform combining advanced exome sequencing, lab tests, and genetics-focused clinician guidance.
New Genetic Studies and Reports
Launched studies on GLP-1 efficacy and genetic reports on emotional eating, along with improvements to ancestry composition and historical matches features.
Improved Financial Metrics
Improved GAAP net loss by 21% and adjusted EBITDA by 26% compared to the same period in the prior year.
---
ME Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ME Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $4.61 | $4.71 | +2.17% |
| Aug 08, 2024 | $7.46 | $7.23 | -3.08% |
| May 23, 2024 | $10.19 | $10.26 | +0.69% |
| Feb 07, 2024 | $14.49 | $12.60 | -13.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does 23andMe Holding (ME) report earnings?
23andMe Holding (ME) is schdueled to report earning on Feb 05, 2025, TBA Not Confirmed.
What is 23andMe Holding (ME) earnings time?
23andMe Holding (ME) earnings time is at Feb 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ME EPS forecast?
Currently, no data Available
---